Farydak

Active Ingredient(s): Panobinostat
FDA Approved: * February 23, 2015
Pharm Company: * NOVARTIS PHARMS CORP
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Farydak Overview

Panobinostat (trade name Farydak /frdæk/ FAIR--dak) is a drug by Novartis for the treatment of various cancers. It is a hydroxamic acid[2] and acts as a non-selective histone deacetylase inhibitor (pan-HDAC inhibitor).[3] On 23 February 2015 it received FDA accelerated approval for use in patients with multiple myeloma,[4][5] and on 28 August 2015 it was approved by the European Medicines Agency for the same use.[6&a...

Read more Farydak Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Panobinostat

Recent Farydak Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Panobinostat
  • Capsule: 10mg, 15mg, 20mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Farydak: (3 results)

Sorted by National Drug Code
  • 0078-0650 Farydak 10 mg Oral Capsule by Novartis Pharmaceuticals Corporation
  • 0078-0651 Farydak 15 mg Oral Capsule by Novartis Pharmaceuticals Corporation
  • 0078-0652 Farydak 20 mg Oral Capsule by Novartis Pharmaceuticals Corporation

Other drugs which contain Panobinostat or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 23 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA